Caricamento...
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
Immune checkpoint blockade (ICB) therapy provides remarkable clinical gains, where melanoma is at the forefront of its success. However, only a subset of patients with advanced tumors currently benefit from these therapies, which at times incur considerable side-effects and costs. Constructing predi...
Salvato in:
| Pubblicato in: | Nat Med |
|---|---|
| Autori principali: | , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6693632/ https://ncbi.nlm.nih.gov/pubmed/30127394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-018-0157-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|